IQVIA Inc.
IQV | NYSE
$269.12
+$2.70 (+1.01%)
Sep 21, 2026, 1:49 PM ET · Market open
Company Profile
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Key Executives
| Name | Position |
|---|---|
| Ari Bousbib | Chief Executive Officer & Chairman |
| Michael J. Fedock | Executive Vice President & Chief Financial Officer |
| Alistair Grenfell | President of Commercial Solutions |
| Duane Sachs | Senior Vice President of Corporate Development |
| Eric Sherbet | Executive Vice President, General Counsel & Secretary |
| James G. Berkshire | Executive Vice President of Global Infrastructure & Operations |
| Jeffrey A. Spaeder | Chief Medical & Scientific Officer |
| Keriann Cherofsky | Senior Vice President, Corporate Controller & Chief Accounting Officer |
| Kerri Joseph | Senior VP of Investor Relations & Treasurer |
| W. Richard Staub | President of Research & Development Solutions |
IQVIA Inc.
| Country | United States |
| IPO Date | May 8, 2013 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 94,000 |
| CEO | Ari Bousbib |
Contact Details
2400 Ellis Road Durham,
North Carolina 27703 United States
Stock Details
| Ticker Symbol | IQV |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001478242 |
| CUSIP Number | 46266C105 |
| ISIN Number | US46266C1053 |
| SIC Code | 8731 |
Recent News
- 15 hours ago / defenseworld.netContrasting IQVIA (NYSE:IQV) and Bullfrog AI (NASDAQ:BFRG)
- 5 days ago / zacks.comIQVIA Stock Rises 60% in 6 Months: Here's What You Should Know
- 10 days ago / zacks.comWhy IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term
- 25 days ago / zacks.comWhy Is IQVIA (IQV) Up 5.6% Since Last Earnings Report?
- 26 days ago / zacks.comHere's Why You Should Retain IQVIA Stock in Your Portfolio Now
- 1 month ago / defenseworld.netBlackRock Inc. Takes Position in IQVIA Holdings Inc. $IQV
- 1 month ago / zacks.comIQV Stock Gains 42% in 3 Months: Here's What You Should Know
- 1 month ago / zacks.comWhy IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term
- 2 months ago / zacks.comIQVIA Holdings (IQV) is a Top-Ranked Momentum Stock: Should You Buy?
- 2 months ago / zacks.comIs IQVIA Stock a Buy as Growth Improves but High Leverage Persists?
Add to Watchlist
Select watchlists to add or remove IQV